Top

Published in:

Open Access 01-12-2017 | Research article

Situational analysis of antibiotic use and resistance in Ghana: policy and regulation

Authors: Saviour Kwame Yevutsey, Kwame Ohene Buabeng, Moses Aikins, Berko Panyin Anto, Richard B. Biritwum, Niels Frimodt-Møller, Martha Gyansa-Lutterodt

Published in: BMC Public Health | Issue 1/2017

Abstract

Background

Antibiotics have played an essential role in decreasing morbidity and mortality from infectious diseases. However, indiscriminate use and unrestricted access is contributing to the emergence of bacterial resistance. This paper reports on a situational analysis of antimicrobial use and resistance in Ghana, with focus on policy and regulation.

Methods

Relevant policy documents, reports, regulations and enactments were reviewed. PubMed and Google search engines were used to extract relevant published papers. Websites of stakeholders such as Ministry of Health (MOH) and its agencies were also reviewed. An interview guide was used to elicit responses from selected officials from these sectors.

Results

Laws and guidelines to control the use of antimicrobials in humans were available but not for animals. There was no National Antimicrobial Policy (NAP). A health practice regulatory law mandates Physicians, Physician Assistants, Midwives and trained Nurses to prescribe antimicrobials. However, antibiotics are widely prescribed and dispensed by unauthorised persons, suggesting weak enforcement of the laws. Antibiotics were also supplied to and from unapproved medicine outlets. The Standard Treatment Guidelines (STG), Essential Medicines List (EML) and the National Health Insurance Scheme Medicines List (NHISML) provide restrictions regarding levels of prescribing of antimicrobials. However, existing guidelines on antibiotic use are mostly not adhered to. The use of Automatic Stop Orders to avoid wastage in the hospitals is also not practiced. Data on use of antibiotics for individuals are not readily available in most facilities. Again, there are no standards or guidelines on veterinary use of antibiotics. Surveillance systems for consumption of antibiotics and resistance monitoring were not in place in most health facilities. However, there is an ongoing national action to create awareness on bacteria resistance, strengthening knowledge through research and surveillance and development of NAP in line with global action plan on antimicrobial resistance.

Conclusion

Absence of national antimicrobial policy, weak regulatory environment and non-adherence to practice standards may have contributed to increased and unregulated access to antimicrobials in Ghana, a catalyst for development and spread of antimicrobial resistance.

Available only for authorised users

World Health Organization. Overcoming antimicrobial resistance World Health Organization report on infectious diseases. Geneva: Geneva: World Health Organization; 2000. [cited 2016 Jul 13]. Available from: www.who.int/iris/handle/10665/66672

Jarvis WR. Controlling healthcare -associated infections: the role of infection control and antimicrobial use practices. Semin Infect Dis. 2004;15(1):30–40.CrossRef

Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5(9):568–80. [cited 2016 Jul 11]. Available from: http://www.thelancet.com/article/S1473309905702176/fulltext CrossRefPubMed

Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus Aureus in Canadian hospitals. Infect Control Hosp Epidemiol. 2001;22(2):99–104. [cited 2016 Jul 8]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11232886 CrossRefPubMed

Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9. [cited 2016 Jul 6]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16355321 CrossRefPubMed

European Medicines Agency. The bacterial challenge: time to react. 2009 [cited 2016 Jul 6]; Available from: www.ecdc.europa.eu

Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, et al. Excess Costs and utilization associated with Methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010;31(4):365–73. [cited 2016 Jul 6]. Available from: http://www.jstor.org/stable/10.1086/651094 CrossRefPubMed

Gilbert DM. The Sanford guide to antimicrobial therapy. VA: Antimicrobial Therapy Inc.; 2008.

Newman MJ. Multiple-resistant Salmonella group G outbreak in a neonatal intensive care unit. West Afr J Med. 1996;15(3):165–9. [cited 2016 Jul 11]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9014507 PubMed

10.

Newman MJ, Frimpong E, Donkor ES, Opintan JA, Asamoah-Adu A. Resistance to antimicrobial drugs in Ghana. Infect Drug Resist. 2011;4:215–20. [cited 2016 Jul 6]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22259250 PubMedPubMedCentral

11.

Duplessis C, Puplampu N, Nyarko E, Carroll J, Dela H, Mensah A, et al. Gonorrhea surveillance in Ghana, Africa. Mil Med. 2015;180(1):17–22. [cited 2016 Jul 13]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25562852 CrossRefPubMed

12.

Commey JO, Rodrigues OP, Akita FA, Newman M. Bacterial meningitis in children in southern Ghana. East Afr Med J. 1994;71(2):113–7. [cited 2016 Jul 13]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7925039 PubMed

13.

Dayie NT, Arhin RE, Newman MJ, Dalsgaard A, Bisgaard M, Frimodt-Møller N, et al. Penicillin resistance and serotype distribution of streptococcus pneumoniaein Ghanaian children less than six years of age. BMC Infect Dis. 2013;13(1):490. [cited 2016 Jul 13]. Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-490 CrossRefPubMedPubMedCentral

14.

Baird RW. Antibiotic prescribing, controls and antimicrobial resistance: an Australian experience. APUA Newsl. 1997;15(4):1–2,6.

15.

Wenzel RP, Edmond MB. Managing antibiotic resistance. N Engl J Med. 2000;343(26):1961–3. [cited 2016 Jul 13]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11136269 CrossRefPubMed

16.

Infections I of M (US) F on E, Knobler SL, Lemon SM, Najafi M, Burroughs T. Factors contributing to the emergence of resistance. 2003;

17.

Levy SB. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002;49(1):25–30. [cited 2016 Jul 14]. Available from: http://www.jac.oupjournals.org/cgi/doi/10.1093/jac/49.1.25 CrossRefPubMed

18.

Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013;6:CD000247. [cited 2016 Jul 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23733381

19.

Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T [Internet]. 2015;40(5):344–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25987823

20.

Ministry of Health. Ghana national drug policy. Accra: Yamens Press. Ltd Accra; 2004.

21.

Ministry of Health. Ministry of Health | Ghana official website [internet]. Role and function. 2015. Available from: http://www.moh.gov.gh/.

22.

Wolf-Gould CS, Taylor N, Horwitz SM, Barry M. Misinformation about medications in rural Ghana. Soc Sci Med. 1991;33(1):83–9. [cited 2016 Jul 13]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1882245 CrossRefPubMed

23.

Senah KA. Money be man: The popularity of medicines in a rural Ghanaian community. Amsterdam: Het Spinhuis Publishers; 1997.

24.

Health Professions Regulatory Body Act, 857. Ghana: Ghana Publishing Corporation; 2013.

25.

Public Health Act, 851, Ghana. Ghana Publishing Corporation, 2012.

26.

Food and Drugs Authority. Revised drug classification list [internet]. 2015. Available from: http://www.fdaghana.gov.gh/.

27.

Tagoe DNA, Attah CO. A study of antibiotic use and abuse in Ghana: a case study of the Cape Coast Metropolis. Internet J Health. 2010;11(2). doi:10.5580/bec.

28.

Donkor E, Tetteh-Quarcoo P, Nartey P, Agyeman I. Self-medication practices with antibiotics among tertiary level students in Accra, Ghana: a cross-sectional study. Int J Environ Res Public Health. 2012;9(12):3519–29. [cited 2016 Jul 6]. Available from: http://www.mdpi.com/1660-4601/9/10/3519/ CrossRefPubMedPubMedCentral

29.

Ahiabu M-A, Tersbøl BP, Biritwum R, Bygbjerg IC, Magnussen P. A retrospective audit of antibiotic prescriptions in primary health-care facilities in eastern region, Ghana. Health Policy Plan. 2016;31(2):250–8. [cited 2017 Feb 16]. Available from: https://academic.oup.com/heapol/article-lookup/doi/10.1093/heapol/czv048 CrossRefPubMed

30.

Arhinful DK. WHO pharmaceutical situation assessment – LEVEL II – health facilities survey in GHANA. 2008;

31.

Afriyie EO, Edusei AK, Mensah KA, Nkoom B, Okyere P, Adjei RO, et al. Antibiotics Availability and Usage in Health Facilities: A Case of the Offinso-South Municipality of Ghana. J Biol. 2015;5(2):132–8.

32.

World Health Organization. Drug and therapeutics committees A practical guide. France; 2003. Available on: http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf.

33.

Pharmacy Unit. Institutionalizing rational use of medicines in Ghana. Accra: Multiple Impression; 2008.

34.

National Health Insurance Authority. National Health Insurance Scheme Medicine List. Accra: National Health Insurance Authority; 2013.

35.

Gelband H, Delahoy M. Policies to address antibiotic resistance in low-and middle-income countries. 2014 [cited 2017 May 15]; Available from: https://www.cddep.org/wp-content/uploads/2017/06/abrinlmics_cddep_gelband_and_delahoy_9-14.pdf

36.

Osei Sekyere J, Osei Sekyere J. Antibiotic types and handling practices in disease management among pig farms in Ashanti Region, Ghana. J Vet Med [Internet]. 2014;2014:1–8. Available from: http://www.hindawi.com/journals/jvm/2014/531952/. [cited 2016 Jul 11].

37.

Nisha A. Antibiotic residues - a Global Health hazard. Vet World. 2008;2(2):375. [cited 2017 May 15]. Available from: http://www.veterinaryworld.org/2008/December/8.html CrossRef

38.

Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. [cited 2017 May 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24591853 PubMedPubMedCentral

39.

De Bruycker M, Van den Bergh R, Dahmane A, Khogali M, Schiavetti B, Nzomukunda Y, et al. Non-adherence to standard treatment guidelines in a rural paediatric hospital in Sierra Leone. Public Heal action. 2013;3(2):118–24. [cited 2017 May 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26393013 CrossRef

40.

Willemsen I, Bogaers-Hofman D, Winters M, Kluytmans J. Correlation between antibiotic use and resistance in a hospital: Temporary and ward-specific observations. Infection. 2009;37(5):432–7. [cited 2017 May 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19499184 CrossRefPubMed

41.

Global Action Plan On Antimicrobial Resistance. [cited 2017 May 15]; Available from: http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf

42.

Pharmacy Unit. Pharmaceutical Sector Annual Report. Accra: Ministry of Health; 2014.

43.

Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T [Internet]. 2015;40(4):277–83. [cited 2017 May 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25859123

44.

Vialle-Valentin CE, LeCates RF, Zhang F, Desta AT, Ross-Degnan D. Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countries. Trop Med Int Heal. 2012;17(2):211–22. [cited 2017 May 15]. Available from: http://doi.wiley.com/10.1111/j.1365-3156.2011.02895.x CrossRef

45.

Newman MJ, Frimpong E, Donkor ES, Opintan JA, Asamoah-Adu A. Resistance to antimicrobial drugs in Ghana. Infect Drug Resist. 2011;4:215–20. [cited 2016 Jul 11]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22259250 PubMedPubMedCentral

46.

Gross U, Amuzu SK, de Ciman R, Kassimova I, Gross L, Rabsch W, et al. Bacteremia and antimicrobial drug resistance over time, Ghana. Emerg Infect Dis. 2011;17(10):1879–82. [cited 2016 Jul 7]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22000360 CrossRefPubMedPubMedCentral

47.

Djie-Maletz A, Reither K, Danour S, Anyidoho L, Saad E, Danikuu F, et al. High rate of resistance to locally used antibiotics among enteric bacteria from children in northern Ghana. J Antimicrob Chemother. 2008;61(6):1315–8. [cited 2016 Jul 6]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18356156 CrossRefPubMed

Title: Situational analysis of antibiotic use and resistance in Ghana: policy and regulation
Authors: Saviour Kwame Yevutsey
Kwame Ohene Buabeng
Moses Aikins
Berko Panyin Anto
Richard B. Biritwum
Niels Frimodt-Møller
Martha Gyansa-Lutterodt
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2017
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-017-4910-7

At a glance: The STEP trials

Springer Medicine

Situational analysis of antibiotic use and resistance in Ghana: policy and regulation

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Prevalence and associated risk factors for Giardia and Cryptosporidium infections among children of northwest Mexico: a cross-sectional study

Do objective neighbourhood characteristics relate to residents’ preferences for certain sports locations? A cross-sectional study using a discrete choice modelling approach

Accessing physical activity among young adults attending a university: the role of sex, race/ethnicity, technology use, and sleep

Schistosomiasis mansoni incidence data in Rwanda can improve prevalence assessments, by providing high-resolution hotspot and risk factors identification

Cause of neonatal deaths in Northern Ethiopia: a prospective cohort study

The Stepping Stones and Creating Futures intervention to prevent intimate partner violence and HIV-risk behaviours in Durban, South Africa: study protocol for a cluster randomized control trial, and baseline characteristics